ALXO as of Oct 30 · 21:17 ET
ALXONasdaqPharmaceutical Preparations

ALX Oncology Holdings Inc · Brief

Next report

6 days

Nov 6 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±51.4%▲+9.90%×0.19
quarterimplied−55%0+55%realized×
Q2 FY26±51.4%▲+9.90%×0.19
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 6 report · est.

Bull2

94managers reporting a position in the latest quarterly filings13F · Jun 30 '26
15disclosed supplier and customer ties in SEC filingsSEC filings

Bear1

6 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

ALXO report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 23impliedImplied move: ±53.4% into Nov 6 earnings (Oct 23 close).Source
Oct 158-KMaterial agreement: Exchange Agreement with Blackstone Annex Master Fund L.P.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.